Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine (Q36852626)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2013
edit
Language Label Description Also known as
English
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine
scientific article published on June 2013

    Statements

    Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    Herve J Fleury
    Claudia A Hawkins
    Weerawat Manosuthi
    Laurent Belec
    Sherri Burda
    Alaka K Deshpande
    Ziad El-Katib
    Jean-Chrysostome Gody
    Nicolas A Margot
    Sandrine Moussa
    Phillipe N Nyambi
    Rob Schuurman
    Sunee Sirivichayakul
    Michael R Jordan
    1 June 2013
    207 Suppl 2
    S70-7

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit